Refractory Malignant Solid Neoplasm
Showing NaN - NaN of 31
Recurrent Malignant Solid Tumor, Recurrent Osteosarcoma, Refractory Malignant Solid Tumor Trial in United States (Laboratory
Active, not recruiting
- Recurrent Malignant Solid Neoplasm
- +3 more
- Laboratory Biomarker Analysis
- +2 more
-
Birmingham, Alabama
- +23 more
Apr 22, 2022
Advanced Malignant Solid Tumor, Refractory Malignant Solid Tumor Trial in United States (Adavosertib)
Suspended
- Advanced Malignant Solid Neoplasm
- Refractory Malignant Solid Neoplasm
-
Duarte, California
- +8 more
Mar 15, 2022
Advanced Malignant Solid Tumor, KRAS Gene Mutation, Ovarian Carcinoma Trial in Houston (Paclitaxel, Pharmacokinetic Study,
Active, not recruiting
- Advanced Malignant Solid Neoplasm
- +4 more
- Paclitaxel
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Dec 13, 2021
Metastatic Malignant Solid Tumor, Refractory Malignant Solid Tumor, Unresectable Malignant Solid Tumor Trial in Houston
Recruiting
- Metastatic Malignant Solid Neoplasm
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Nov 16, 2021
Recurrent Cutaneous Melanoma, Recurrent Lip and Oral Cavity Carcinoma, Recurrent Malignant Endocrine Tumor Trial in Houston
Recruiting
- Recurrent Cutaneous Melanoma
- +27 more
- Cord Blood-derived Expanded Allogeneic Natural Killer Cells
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Apr 28, 2021
Childhood Solid Tumor, Recurrent Malignant Solid Tumor, Recurrent Primary CNS Tumor Trial in United States (Laboratory Biomarker
Completed
- Childhood Solid Neoplasm
- +4 more
- Laboratory Biomarker Analysis
- +2 more
-
Birmingham, Alabama
- +20 more
Apr 12, 2021